Anixa Biosciences Inc — Director's Dealing 2014

Jan 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-01-23

Reporting Person: KUMAR AMIT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-23	Common Stock	P	12000	$0.27	Acquired	205004	Direct
2014-01-23	Common Stock	P	5000	$0.275	Acquired	210004	Direct
2014-01-23	Common Stock	P	8000	$0.2895	Acquired	218004	Direct
2014-01-23	Common Stock	P	10000	$0.265	Acquired	228004	Direct
2014-01-23	Common Stock	P	57352	$0.29	Acquired	285356	Direct
2014-01-23	Common Stock	P	42648	$0.295	Acquired	328004	Direct